NIH-funded research R01 grant

How a viral protein affects HIV persistence in immune cells

Official title: Impact of Vpr-induced epigenetic remodeling on HIV persistence

Funded at University of Texas Hlth Science Center · NIH-11187705 · Data updated 2026-11-12

This study is looking at how a specific HIV protein called Vpr helps the virus stay hidden in certain immune cells, and by learning more about this process, researchers hope to find new ways to help people with HIV by getting rid of the virus for good.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center
NIH-funded
Lab location1 site (San Antonio, United States)
Project startApril 23, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$624,902
NIH project number1R01AI189230-01A1
Project IDNIH-11187705 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV, particularly those with persistent viral reservoirs despite antiretroviral therapy.

Less likely to help

Patients who are not infected with HIV or those who have acute HIV infections without established reservoirs may not benefit from this research.

What this research studies

This research investigates the role of the HIV protein Vpr in maintaining the virus within certain immune cells, particularly myeloid cells. By understanding how Vpr induces changes in the genetic material of these cells, the study aims to uncover new ways to target and eliminate long-lasting HIV reservoirs. The approach involves detailed laboratory experiments to analyze the mechanisms by which Vpr influences HIV persistence, potentially leading to innovative treatment strategies. Patients may benefit from insights that could contribute to the development of a cure for HIV.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that effectively eliminate HIV reservoirs, potentially curing patients of the virus.

How similar studies have gone: Previous research has shown promise in targeting viral reservoirs, but the specific approach of studying Vpr's role in myeloid cells is relatively novel.

Where this research is happening

  • University of Texas Hlth Science Center
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Salamango, Daniel James — University of Texas Hlth Science Center
  • Study coordinator: Salamango, Daniel James

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.